Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines

Sons, 1987, Etiology and epidemiology of carcinoma of the esophagus, Surg. Gynecol. Obstet., 165, 183 Jiang, 1992, Amplification and expression of the human cyclin D gene in esophageal cancer, Cancer Res, 52, 2980 Jiang, 1993, Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer, 90, 9026 Nakagawa, 1995, Human cyclin D1 oncogene and esophageal squamous cell carcinoma, Cancer, 76, 541, 10.1002/1097-0142(19950815)76:4<541::AID-CNCR2820760402>3.0.CO;2-I Hollstein, 1988, Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers, Cancer Res, 48, 5119 Hollstein, 1990, Frequent mutation of the p53 gene in human esophageal cancer, 87, 9958 Bennett, 1992, p53 mutation and protein accumulation during multistage human esophageal carcinogenesis, Cancer Res., 52, 6092 Meltzer, 1991, Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction, 88, 4976 Hollstein, 1991, Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations, Cancer Res., 51, 4102 Mori, 1994, Cancer Res., 54, 3396 Liu, 1995, MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines, Oncogene, 10, 619 Stoner, 1995, Biology of esophagus squamous cell carcinoma, 141 Kapil, 1993, Vitamin A and esophageal cancer, Trop. Gastroenterol., 14, 87 Swaroop, 1989, Nutrition and esophageal cancer, 5, 370 Lotan, 1994, Suppression of squamous cell carcinoma growth and differentiation by retinoids, Cancer Res., 54, 1987s Zou, 1994, Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines, Cancer Res., 54, 5479 Heyman, 1992, 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell, 68, 397, 10.1016/0092-8674(92)90479-V Xu, 1994, Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues, Cancer Res., 54, 3580 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72, 248, 10.1016/0003-2697(76)90527-3 Lotan, 1993, Retinoids and squamous cell differentiation, 43 DeLuca, 1991, Retinoids and their receptors in differentiation, embryogenesis and neoplasia, FASEB J., 5, 2924, 10.1096/fasebj.5.14.1661245 Jetten, 1992, Control of squamous differentiation in tracheobronchial and epidermal epithelial cells: role of retinoids, J. Natl. Cancer Inst. Monogr., 13, 93 Lippman, 1987, Retinoids as preventive and therapeutic anticancer agents (part III), Cancer Treat. Rep., 71, 493 DiVinci, 1994, Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl) retinamide, Int. J. Cancer, 59, 422, 10.1002/ijc.2910590322 Delia, 1993, N-(4-Hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid, Cancer Res., 53, 6036 Miller, 1994, All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-α and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas, Differentiation, 55, 145, 10.1046/j.1432-0436.1994.5520145.x